1. Home
  2. JBLU vs HRMY Comparison

JBLU vs HRMY Comparison

Compare JBLU & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$4.42

Market Cap

1.9B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$28.39

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBLU
HRMY
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
JBLU
HRMY
Price
$4.42
$28.39
Analyst Decision
Sell
Buy
Analyst Count
12
10
Target Price
$5.20
$46.70
AVG Volume (30 Days)
14.5M
1.1M
Earning Date
04-27-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
27.83
7.97
EPS
N/A
2.71
Revenue
$9,062,000,000.00
$868,453,000.00
Revenue This Year
$10.10
$19.87
Revenue Next Year
$7.91
$12.49
P/E Ratio
N/A
$10.46
Revenue Growth
N/A
21.51
52 Week Low
$3.34
$25.52
52 Week High
$6.46
$40.87

Technical Indicators

Market Signals
Indicator
JBLU
HRMY
Relative Strength Index (RSI) 33.25 31.77
Support Level $4.04 $26.36
Resistance Level $4.88 $37.38
Average True Range (ATR) 0.34 1.82
MACD -0.19 -0.21
Stochastic Oscillator 7.67 21.42

Price Performance

Historical Comparison
JBLU
HRMY

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: